Pages that link to "Q34368505"

The following pages link to On the mechanism of CFTR inhibition by a thiazolidinone derivative (Q34368505):

Displaying 35 items.

• Identification of resveratrol oligomers as inhibitors of cystic fibrosis transmembrane conductance regulator by high-throughput screening of natural products from chinese medicinal plants (Q28537590) (← links)
• Acetylcholine released by endothelial cells facilitates flow-mediated dilatation (Q28817402) (← links)
• Impact of the F508del mutation on ovine CFTR, a Cl- channel with enhanced conductance and ATP-dependent gating. (Q30372632) (← links)
• A survey of detergents for the purification of stable, active human cystic fibrosis transmembrane conductance regulator (CFTR). (Q34221261) (← links)
• A single amino acid substitution in CFTR converts ATP to an inhibitory ligand (Q34262494) (← links)
• Rhodanine as a scaffold in drug discovery: a critical review of its biological activities and mechanisms of target modulation. (Q34274409) (← links)
• Cystic fibrosis transmembrane conductance regulator chloride channel blockers: Pharmacological, biophysical and physiological relevance (Q34408604) (← links)
• CFTR inhibitors (Q34553829) (← links)
• Mechanisms of CFTR functional variants that impair regulated bicarbonate permeation and increase risk for pancreatitis but not for cystic fibrosis (Q35208307) (← links)
• CFTR and sphingolipids mediate hypoxic pulmonary vasoconstriction (Q35279508) (← links)
• Divergent CFTR orthologs respond differently to the channel inhibitors CFTRinh-172, glibenclamide, and GlyH-101 (Q35895699) (← links)
• Identification of a novel post-hydrolytic state in CFTR gating (Q35931859) (← links)
• Benzopyrimido-pyrrolo-oxazine-dione (R)-BPO-27 Inhibits CFTR Chloride Channel Gating by Competition with ATP (Q36077753) (← links)
• Molecular modelling and molecular dynamics of CFTR. (Q36158194) (← links)
• An Optimised Human Cell Culture Model for Alveolar Epithelial Transport. (Q36174165) (← links)
• Nonintegral stoichiometry in CFTR gating revealed by a pore-lining mutation (Q36277880) (← links)
• Cysteine scanning of CFTR's first transmembrane segment reveals its plausible roles in gating and permeation (Q36621953) (← links)
• New use for an old drug: COX-independent anti-inflammatory effects of sulindac in models of cystic fibrosis. (Q36903409) (← links)
• How Phosphorylation and ATPase Activity Regulate Anion Flux though the Cystic Fibrosis Transmembrane Conductance Regulator (CFTR). (Q37078641) (← links)
• Acute inhibition of the cystic fibrosis transmembrane conductance regulator (CFTR) Cl- channel by thyroid hormones involves multiple mechanisms (Q37234590) (← links)
• CFTR pharmacology. (Q38972431) (← links)
• Synergistic Potentiation of Cystic Fibrosis Transmembrane Conductance Regulator Gating by Two Chemically Distinct Potentiators, Ivacaftor (VX-770) and 5-Nitro-2-(3-Phenylpropylamino) Benzoate (Q39603833) (← links)
• Functional reconstitution and channel activity measurements of purified wildtype and mutant CFTR protein (Q39739811) (← links)
• Loop diuretics are open-channel blockers of the cystic fibrosis transmembrane conductance regulator with distinct kinetics (Q42622816) (← links)
• Guanylin peptides regulate electrolyte and fluid transport in the Gulf toadfish (Opsanus beta) posterior intestine. (Q45001876) (← links)
• 5-Ene-4-thiazolidinones - An efficient tool in medicinal chemistry (Q47845542) (← links)
• A role for the cystic fibrosis transmembrane conductance regulator in the nitric oxide-dependent release of Cl- from acidic organelles in amacrine cells. (Q47913748) (← links)
• A common mechanism for CFTR potentiators (Q48111581) (← links)
• Benzopyrimido-pyrrolo-oxazine-dione CFTR inhibitor (R)-BPO-27 for antisecretory therapy of diarrheas caused by bacterial enterotoxins. (Q51313072) (← links)
• Structural mechanisms of CFTR function and dysfunction. (Q52629670) (← links)
• Impact of the cystic fibrosis mutation F508del-CFTR on renal cyst formation and growth (Q57762189) (← links)
• Functional characterization reveals that zebrafish CFTR prefers to occupy closed channel conformations (Q60924938) (← links)
• CFTR channel pharmacology: insight from a flock of clones. Focus on “Divergent CFTR orthologs respond differently to the channel inhibitors CFTRinh-172, glibenclamide, and GlyH-101” (Q85094105) (← links)
• State-dependent blocker interactions with the CFTR chloride channel: implications for gating the pore (Q87527091) (← links)
• Differential thermostability and response to cystic fibrosis transmembrane conductance regulator potentiators of human and mouse F508del-CFTR (Q93000176) (← links)